S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 10.8 CNY -5.1% Market Closed
Market Cap: 13.5B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Shenzhen Hepalink Pharmaceutical Group Co Ltd stock under the Base Case scenario is 12.99 CNY. Compared to the current market price of 10.8 CNY, Shenzhen Hepalink Pharmaceutical Group Co Ltd is Undervalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
12.99 CNY
Undervaluation 17%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Shenzhen Hepalink Pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Shenzhen Hepalink Pharmaceutical Group Co Ltd

Provide an overview of the primary business activities
of Shenzhen Hepalink Pharmaceutical Group Co Ltd.

What unique competitive advantages
does Shenzhen Hepalink Pharmaceutical Group Co Ltd hold over its rivals?

What risks and challenges
does Shenzhen Hepalink Pharmaceutical Group Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide P/S
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide P/E
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide P/OCF
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide P/FCFE
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide P/B
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide EV/S
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide EV/GP
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide EV/EBITDA
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide EV/EBIT
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide EV/OCF
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide EV/FCFF
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide EV/IC
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Show me price targets
for Shenzhen Hepalink Pharmaceutical Group Co Ltd made by professional analysts.

What are the Revenue projections
for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

How accurate were the past Revenue estimates
for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

What are the Net Income projections
for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

How accurate were the past Net Income estimates
for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

What are the EPS projections
for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

How accurate were the past EPS estimates
for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

What are the EBIT projections
for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

How accurate were the past EBIT estimates
for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Compare the revenue forecasts
for Shenzhen Hepalink Pharmaceutical Group Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shenzhen Hepalink Pharmaceutical Group Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shenzhen Hepalink Pharmaceutical Group Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shenzhen Hepalink Pharmaceutical Group Co Ltd compared to its peers.

Compare the P/E ratios
of Shenzhen Hepalink Pharmaceutical Group Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shenzhen Hepalink Pharmaceutical Group Co Ltd with its peers.

Analyze the financial leverage
of Shenzhen Hepalink Pharmaceutical Group Co Ltd compared to its main competitors.

Show all profitability ratios
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide ROE
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide ROA
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide ROIC
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide ROCE
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide Gross Margin
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide Operating Margin
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide Net Margin
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide FCF Margin
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Show all solvency ratios
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide D/E Ratio
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide D/A Ratio
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide Interest Coverage Ratio
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide Altman Z-Score Ratio
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide Quick Ratio
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide Current Ratio
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Provide Cash Ratio
for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

What is the historical Revenue growth
over the last 5 years for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

What is the historical Net Income growth
over the last 5 years for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

What is the current Free Cash Flow
of Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Current Assets 10.7B
Cash & Short-Term Investments 2.7B
Receivables 1.8B
Other Current Assets 6.2B
Non-Current Assets 7.9B
Long-Term Investments 1.9B
PP&E 2.6B
Intangibles 2.8B
Other Non-Current Assets 492.1m
Current Liabilities 4.5B
Accounts Payable 378.2m
Accrued Liabilities 147.8m
Short-Term Debt 1.6B
Other Current Liabilities 2.3B
Non-Current Liabilities 2B
Long-Term Debt 1.6B
Other Non-Current Liabilities 388.4m
Efficiency

Earnings Waterfall
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Revenue
5.5B CNY
Cost of Revenue
-3.7B CNY
Gross Profit
1.8B CNY
Operating Expenses
-2B CNY
Operating Income
-183.9m CNY
Other Expenses
37.6m CNY
Net Income
-146.3m CNY

Free Cash Flow Analysis
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shenzhen Hepalink Pharmaceutical Group Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative Operating Income
42/100
Profitability
Score

Shenzhen Hepalink Pharmaceutical Group Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shenzhen Hepalink Pharmaceutical Group Co Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
62/100
Solvency
Score

Shenzhen Hepalink Pharmaceutical Group Co Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Wall Street analysts forecast Shenzhen Hepalink Pharmaceutical Group Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Hepalink Pharmaceutical Group Co Ltd is 7.45 CNY with a low forecast of 7.37 CNY and a high forecast of 7.67 CNY.

Lowest
Price Target
7.37 CNY
32% Downside
Average
Price Target
7.45 CNY
31% Downside
Highest
Price Target
7.67 CNY
29% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shenzhen Hepalink Pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shenzhen Hepalink Pharmaceutical Group Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

13.5B CNY

Dividend Yield

0%

Description

Shenzhen Hepalink Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shenzhen, Guangdong and currently employs 2,046 full-time employees. The company went IPO on 2010-05-06. Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based pharmaceutical company focused on the field of heparin sodium preparations and raw materials, macromolecular drugs contract development manufacturing organization (CDMO) and innovative drug development. The Company’s main products and services include enoxaparin sodium preparations and heparin sodium bulk medicines, enoxaparin sodium bulk medicines, and CDMO services for macromolecular drugs. The firm distributes its products within the domestic market and to overseas markets, including Turkey, Brazil, the United States and others.

Contact

GUANGDONG
Shenzhen
No. 21, Langshan Road, Songpingshan, Nanshan District
+8675526980311.0
www.hepalink.com

IPO

2010-05-06

Employees

2 046

Officers

Co-Founder, Chairman of the Board & President
Mr. Li Li
Co-Founder, GM, Group VP & Executive Director
Mr. Yu Shan
VP of Finance, CFO & Financial Controller
Ms. Juan Chen
VP, Deputy GM & Director
Ms. Tan Li
Company Secretary
Mr. Fengqi Qian
Chief Business Officer
Ms. Tao Han M.B.A.
Show More
Senior Vice President of Global Supply Chain
Mr. Xi Gao
Show Less

See Also

Discover More
What is the Intrinsic Value of one Shenzhen Hepalink Pharmaceutical Group Co Ltd stock?

The intrinsic value of one Shenzhen Hepalink Pharmaceutical Group Co Ltd stock under the Base Case scenario is 12.99 CNY.

Is Shenzhen Hepalink Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 10.8 CNY, Shenzhen Hepalink Pharmaceutical Group Co Ltd is Undervalued by 17%.

Back to Top